# Maintenance Study on the Long Term Safety of XL999

> **NCT00955084** · PHASE1 · COMPLETED · sponsor: **Symphony Evolution, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Advanced Malignancies

## Interventions

- **DRUG:** XL999

## Key facts

- **NCT ID:** NCT00955084
- **Lead sponsor:** Symphony Evolution, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2010-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955084, "Maintenance Study on the Long Term Safety of XL999". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00955084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
